Matthew Maryniak is President of Fenix Group International, LLC, playing a key role in developing cutting-edge technology to redefine the approach to market intelligence in the life sciences industry. Since FENIX's inception in 2015, Matthew has been at the forefront of leveraging innovative solutions to address market opportunities in life sciences. Previously, he finished as a Principal at IQVIA. Beyond work, Matthew enjoys golfing and traveling with his wife and two daughters. For more on Matthew's professional journey, visit https://www.linkedin.com/in/matthewmaryniak/.

Fenix Group International, LLC, known as FGI Life Sciences outside the US and Switzerland, is a global life sciences consulting firm established in 2015. From our inception, there was a distinct belief that life science consulting firms absent a technology offering will eventually become obsolete. Led by President Matthew Maryniak, our team of 100+ employees integrates cutting-edge technology created by FENIX Labs, our in-house software engineering team, with world-class management consulting. Services include market intelligence, strategic workshops, and custom technology builds that incorporate machine learning and natural language processing. In 2022, we surpassed $10M in top-line revenue for the first time, achieving a 7-year CAGR of 35% - 3.5x above the average in life sciences services. See all that we have to offer at www.fenix.group.